[HTML][HTML] Morphine counteracts the effects of paclitaxel in triple-negative breast cancer cells

G Sezer, A Caner, MG Önal… - Indian Journal of Medical …, 2022 - journals.lww.com
Methods: MDA. MB. 231 cells were treated with paclitaxel in the presence or absence of
morphine and examined for cell proliferation by the MTT assay. In addition, the effect of …

Morphine can inhibit the growth of breast cancer MCF-7 cells by arresting the cell cycle and inducing apoptosis

Y Chen, Y Qin, L Li, J Chen, X Zhang… - Biological and …, 2017 - jstage.jst.go.jp
Morphine is widely used for relieving cancer pain in patients with advanced cancer.
However, whether morphine can suppress or promote the progression of cancer in breast …

Investigating the effects of morphine on survival and sensitivity to cisplatin in ovarian cancer cells

M Rezaeigazik, M Nabiuni, H Jalali… - Journal of Cell and …, 2019 - jcmr.um.ac.ir
Morphine as an analgesic drug is used frequently in cancer patients. Contradictory results
have been achieved from previous studies related to morphine effects in different …

[PDF][PDF] The effect of morphine on the proliferation of human ovarian epithelial cancer A2780cp cell line

M Nabiuni, H Jalali, M Rezaeigazik - International Journal of Cellular …, 2015 - academia.edu
Background: Morphine is used widely to treat severe pain in some medical conditions
including cancer. Previous studies have shown conflicting reports about the effect of this …

Morphine improved the antitumor effects on MCF-7 cells in combination with 5-Fluorouracil

ZH Ge, ZX Wang, TL Yu, N Yang, Y Sun, CL Hao… - Biomedicine & …, 2014 - Elsevier
Background The most frequently used opioid in cancer pain management is morphine which
remains a cornerstone for the management of cancer pain, due to the largest experience …

Morphine promotes the angiogenesis of postoperative recurrent tumors and metastasis of dormant breast cancer cells

S Cheng, M Guo, Z Liu, Y Fu, H Wu, C Wang, M Cao - Pharmacology, 2019 - karger.com
Background: Surgery plays a significant role in the comprehensive treatment of breast
cancer, and opioids are often the first-choice analgesics in the perioperative period …

Morphine promotes tumor angiogenesis and increases breast cancer progression

S Bimonte, A Barbieri, D Rea, G Palma… - Biomed research …, 2015 - Wiley Online Library
Morphine is considered a highly potent analgesic agent used to relieve suffering of patients
with cancer. Several in vitro and in vivo studies showed that morphine also modulates …

Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma …

LH Cao, HT Li, WQ Lin, HY Tan, L Xie, ZJ Zhong… - Scientific reports, 2016 - nature.com
Morphine is an opioid analgesic drug often used for pain relief in cancer patients. However,
there is growing evidence that morphine may modulate tumor growth, progression and …

The enhanced apoptosis and antiproliferative response to combined treatment with valproate and nicotinamide in MCF-7 breast cancer cells

H Jafary, S Ahmadian, M Soleimani - Tumor Biology, 2014 - Springer
Acetylation of histone is a major player in epigenetic modifications, resulting in open
chromatin structures and, hence, permissive conditions for transcription-factor recruitment to …

[HTML][HTML] Induction of apoptosis and non-apoptosis in human breast cancer cell line (MCF-7) by cisplatin and caffeine

B Niknafs - Iranian biomedical journal, 2011 - ncbi.nlm.nih.gov
Background: Molecular targeted therapy by different cell death inducers are recently
considered in cancer therapy. The aim of this study was to compare the effect of cisplatin …